Rocket One Inc. Common Stock (NASDAQ:RKTO) Short Interest Up 75.3% in July

Posted by George Bondi on Jul 30th, 2026

Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 5,250,294 shares, an increase of 75.3% from the June 30th total of 2,994,254 shares. Approximately 25.3% of the shares of the company are sold short. Based on an average trading volume of 15,841,226 shares, the days-to-cover ratio is currently 0.3 days.

Analyst Ratings Changes

A number of research firms have commented on RKTO. Wall Street Zen cut shares of Rocket One Inc. Common Stock from a “sell” rating to a “strong sell” rating in a research note on Saturday, July 18th. Weiss Ratings upgraded shares of Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, June 23rd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Rocket One Inc. Common Stock presently has an average rating of “Hold” and an average price target of $5.00.

Check Out Our Latest Analysis on RKTO

Rocket One Inc. Common Stock Stock Performance

Shares of Rocket One Inc. Common Stock stock traded up $0.07 during trading hours on Thursday, hitting $0.82. The company’s stock had a trading volume of 2,823,020 shares, compared to its average volume of 5,636,048. The business has a 50 day moving average price of $1.07 and a two-hundred day moving average price of $0.93. Rocket One Inc. Common Stock has a 12-month low of $0.49 and a 12-month high of $2.45. The company has a market cap of $18.41 million, a PE ratio of -1.03 and a beta of 0.93.

Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) last released its earnings results on Friday, May 15th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.03).

Institutional Investors Weigh In On Rocket One Inc. Common Stock

Institutional investors have recently added to or reduced their stakes in the stock. Lido Advisors LLC lifted its stake in Rocket One Inc. Common Stock by 100.0% in the 1st quarter. Lido Advisors LLC now owns 39,000 shares of the company’s stock worth $33,000 after purchasing an additional 19,500 shares in the last quarter. Citadel Advisors LLC purchased a new position in shares of Rocket One Inc. Common Stock during the third quarter valued at about $232,000. DRW Securities LLC purchased a new position in shares of Rocket One Inc. Common Stock during the fourth quarter valued at about $257,000. Virtu Financial LLC bought a new stake in shares of Rocket One Inc. Common Stock in the third quarter worth about $184,000. Finally, Geode Capital Management LLC increased its holdings in shares of Rocket One Inc. Common Stock by 18.0% in the fourth quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock worth $179,000 after purchasing an additional 27,577 shares during the last quarter. 7.08% of the stock is owned by hedge funds and other institutional investors.

Rocket One Inc. Common Stock Company Profile

(Get Free Report)

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.